CGA-TAVI Registry to Evaluate the Predictive Value of a CGA in Predicting TAVI Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-02-28

Study Completion Date

2017-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Registry study to evaluate the predictive value of a comprehensive geriatric assessment with regard to the outcome of a transcatheter aortic valve Implantation.

It will be evaluated which parts of the comprehensive geriatric assessment (CGA) are best suited to predict the therapeutic success of a heart valve Implantation in elderly ( \> 80 years) Patient. Possible participants are all Patient of 80 years or above for whom the implantation of a Edwards Sapien XT aortic valve is planned

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Prospective Segeberg TAVI Registry

NCT03192774

Aortic Valve Stenosis

RECRUITING

Geriatric Assessment and Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement

NCT03173079

Influence of Geriatric Functional State on the Outcome After TAVI Possible Change in Geriatric Assessment After TAVI

COMPLETED

EffecTAVI Registry

NCT05235555

Aortic Stenosis Transcatheter Aortic Valve Replacement TAVI

RECRUITING

Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve Implantation

NCT04503655

Aortic Valve Stenosis Cardiovascular Diseases

COMPLETED NA

Neurocognitive Assessment in TAVI

NCT06120946

Aortic Valve Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transcatheter Aortic Valve Implantation Registry with Comprehensive Geriatric Assessment

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAVI patients of > 79 years

All patients undergoing transcatheter valve implantation with commercially available Edwards SAPIEN XT Transcatheter Heart Valve in participating sites.

Routine data about the intervention (transcatheter valve Implantation) will be collected. In addition, data describing the geriatric status of the patient, including a patient questionnaire evaluating his/her Quality of life will be collected.

TAVI

Intervention Type OTHER

no Intervention planned, Observation only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TAVI

no Intervention planned, Observation only

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled TAVI using Edwards SAPIEN XT Transcatheter Heart Valve
* Compliance with the indications of the instructions for use
* Age of at least 80 years
* Written informed consent